Angiodynamics, Inc. recalls OARtrac PLUS CLINICAL DETECTOR UNIT Catalog Number: OTS-V2-Plus - Product Usage: pre-calibrated PSD sensors are intende…
- Recall date
- November 19, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0710-2020
- FDA classification
- Class II
- Brand / firm
- Angiodynamics, Inc.
- Sold / distributed
- US Nationwide distribution in the states of AZ, GA, MA, NJ, NY, OH, PA.
Why it was recalled
May result in readings outside of the expected accuracy range.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
OARtrac PLUS CLINICAL DETECTOR UNIT Catalog Number: OTS-V2-Plus - Product Usage: pre-calibrated PSD sensors are intended for use during cancer treatments to measure photon and electron radiation therapy as an adjunct to treatment planning permitting measurement and validation of radiation dose received by the patient to the targeted area of their body.
Get recall alerts
Free email alert whenever Angiodynamics, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Angiodynamics, Inc.